How a Reluctant CEO Conquered Imposter Syndrome to Turn Biotech Profitable
A biotech CEO shares her journey from English literature graduate to profitable company leader. Learn how embracing gut instincts, building diverse teams, and overcoming self-doubt transformed her leadership approach and company success.
In the competitive world of biotech leadership, one reluctant CEO’s journey from imposter syndrome to profitability offers powerful lessons in instinct-driven decision-making and authentic leadership. Jamie Stueland’s unconventional path demonstrates how embracing vulnerability while building diverse teams can transform both personal leadership and company outcomes in the drug development sector.